| English Alias: |
Vidarabine;9-beta-D-Arabinosyladenine;(2R,3S,4S,5R)-2-(6-Aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol;6-Amino-9-b-D-arabinofuranosylpurine;9H-Purin-6-amine, 9.β.-D-arabinofuranosyl-;9-β-D-Arabinofuranosyl-adenine;Adenine 9-beta-D-arabinofuranoside;Adenine 9-β-D-arabinofuranoside;ADENINE-BETA-D-ARABINOFURANOSIDE;9-β-D-Arabinofuranosyladenine;Adenine Arabinoside;Ara-A;ara-adenosine;Arabinosyladenine;arasena-a;b-Ara-A;ci673;ci-673;CI763;vidarabin;VIDARBINE;vira-a;Spectrum4_000782;araA;UNII-3XQD2MEW34;V0098;9-.beta.-D-Arabinofuranosyl-9H-purine-6-amine;9-ss -D-Arabinofuranosyladenine;6-Amino-9-beta-D-arabinofuranosylpurine;Adenine 9-ss -D-arabinofuranoside;Vidarabine (Vira-A);CI-673;BCP27778;beta-D-Arabinofuranosyladenine;BRN 0624881;Vidarabina;RAB;MLS001066352;SCHEMBL110914;Q415107;Spectrum5_001429;SR-01000765435-2;5536-17-4;Arabinosyl adenine;9-beta-D-Arabinofuranosyladenine;SPECTRUM1500609;HSDB 6514;Vidarabine (monohydrate);KBio3_001500;Vira A;NC00547;Adenine arabinoside;KBio2_004986;HY-B0277;AB00430250_12;Vidarabine (JAN);Spongoadenosine;KBio1_000191;Vidarabine anhydrous;Adenine 9-beta;-D-arabinofuranoside;KBio2_007554;9-beta-Arabinoadenosine;BSPBio_002000;D06298;Adenine, 9beta-D-arabinofuranosyl-;KBioGR_001224;OIRDTQYFTABQOQ-UHTZMRCNSA-N;DB00194;9-(beta-D-arabinofuranosyl)-9H-adenine;beta-D-Arabinosyladenine;Adenine-9-beta-D-arabinofuranoside;VIDARABINE [MI];DTXSID80873976;Adenine-beta-D-arabinofuranoside;BDBM50144936;HMS1921K05;NCGC00178869-01;Vidarabine, United States Pharmacopeia (USP) Reference Standard;(+)-Cyclaradine;SBI-0051555.P002;AB00430250-09;DS-1755;3XQD2MEW34;NSC 247519;PDSP1_001036;CCRIS 3383;Arabinoside adenine;V0175;Spectrum2_001336;EINECS 226-893-9;Spectrum3_000580;6-amino-9-(beta-D-arabinofuranosyl)purine;2-(6-Amino-purin-9-yl)-5-hydroxymethyl-tetrahydro-furan-3,4-diol;9-BETA-D-ARABINOFURANOSYL-ADENINE;DivK1c_000191;Arasena-A;9-beta-D-arabinofuranosyl adenine;SR-05000001737;9H-Purin-6-amine, 9beta-D-arabinofuranosyl-;Adenine, 9-beta-D-arabinofuranosyl-;HMS3259I08;9beta-D-Arabinofuranosyladenine;Armes (TN);Vidarabine, anhydrous;NSC-247519;HMS2090F06;Vidarabin;CI 673;KBio2_002418;CHEBI:45327;NSC757383;AKOS015919711;Vira-A;HMS2230N24;9H-adenin-9-yl beta-D-arabinofuranoside;VIDARABINE [HSDB];9-(beta-D-Arabinofuranosyl)adenine;HMS3714I18;Vira ATM;NCGC00023673-08;MLS001333133;Araadenosine;Adenine beta-D-arabinofuranoside;CCG-39634;(2R,3S,4S,5R)-2-(6-amino-9H-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol;GTPL4806;HMS500J13;SMR000471872;Adenine 9-ss-D-arabinofuranoside;VIDARABINE [WHO-DD];9--D-arabinofuranosyl-9H-purin-6-amine;PDSP2_001020;HMS2092C16;SMP1_000312;HG1001;Vidarabinum [INN-Latin];AI3-52821;Pharmakon1600-01500609;MFCD00065471;9-beta-D-arabinofuranosyl-9H-purin-6-amine;SR-01000765435;9-b-d-arabinofuranosyladenine;Adenine 9-beta-D-arabinofuranoside, >=99%;NS00124064;AB00430250-08;NSC-404241;MLS00133313... |
